Compass Therapeutics, Inc. (CMPX) Dividend History

Company News

• Top 3 High-Momentum Companies Analysts Are Still Bullish On

  Three companies with recent stock rallies that analysts remain bullish on are Compass Therapeutics, Amprius Technologies, and Allot Communications. Analysts see significant upside potential in these momentum stocks despite their recent gains.

  Investing.com

  Featured Companies: ALLT AMPX
• Compass Therapeutics to Participate in Upcoming Investor Events

  Compass Therapeutics, a clinical-stage biopharmaceutical company, announced its participation in two investor conferences in September 2024, where it will present updates on its oncology-focused pipeline of antibody-based therapeutics.

  GlobeNewswire Inc.
• Compass Therapeutics, Inc. (CMPX) Upgraded to Buy: Here's What You Should Know

  Compass Therapeutics, Inc. (CMPX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

  Zacks Investment Research
• The Russell 2000 Index has soared, but you might be better off looking elsewhere for quality small-cap stocks

  A more selective small-cap index has consistently outperformed the Russell 2000

  MarketWatch

  Featured Companies: ACRV ALLO ARLO ATNM CPRX CRBU DGII DVAX GPRE HLX IJR INZY IPSC IRWD IWM KPTI LCTX LGND MODV PAYO PCRX PRVA PTEN RCUS RLYB RNA SMTC SPY STOK TALO THRY TNYA TRVI VIGL VIR VOR XFOR XNCR XPER
• Why NextGen Healthcare Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket

  Gainers Helius Medical Technologies, Inc. (NASDAQ: HSDT) rose 65.3% to $12.20 in pre-market trading after gaining around 9% on Friday. Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares gained 47.1% to $1.75 in pre-market trading. Crown Electrokinetics is scheduled to hold an investor update conference call on Sept. 18, 2023. Aravive, Inc. (NASDAQ: ARAV) shares rose 28.5% to $0.1799 in pre-market trading after falling 6% on Friday. Applied Molecular Transport Inc. (NASDAQ: AMTI) shares rose 23.3% to $0.2239 in pre-market trading after falling 17% on Friday. Addex Therapeutics Ltd (NASDAQ: ADXN) shares gained 14.5% to $0.5201 in pre-market trading after the company said ADX71149 (JNJ-40411813) Phase 2 epilepsy clinical study is progressing well, with Cohort 1 completed and 80% of patients recruited into Cohort 2. NextGen Healthcare, Inc. (NASDAQ: NXGN) shares climbed 13.4% to $21.93 in pre-market trading. Thoma ...

  Benzinga

  Featured Companies: ADTX EDBL HSDT RELI SRM UIS VFS WORX